No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - GenIP reported strong 2025 operational progress on Thursday, delivering sharp growth in revenues, margins and client numbers as adoption of its integrated invention intelligence products accelerated.
The AIM-traded company said revenue rose by 330% year-on-year, while gross margin increased by around 150% compared with 2024.
Active clients grew by more than 225% over the period, with client retention remaining high at about 90%.
GenIP said performance was driven by the rollout of its integrated product suite and increasing adoption of its Invention Prioritizer offering, with demand from Brazil and Saudi Arabia generating new client introductions and a growing pipeline of inbound enquiries.
The firm said it was continuing to make progress in expanding its corporate client base, with new orders secured and discussions ongoing with both corporate and academic customers.
Demand from universities and other non-corporate organisations remained robust, supported by repeat orders and ongoing international engagement.
As part of this momentum, the National Nuclear Energy Commission of Brazil placed an order for the Invention Prioritizer product to assess an initial portfolio of 20 technologies, with the potential to extend the engagement to a further 20 technologies subject to performance and client requirements.
The Invention Prioritizer, launched in November 2024, had also been applied to several hundred technologies for a leading research university in Saudi Arabia, with that engagement leading to introductions to additional academic institutions in the region.
GenIP said early traction was also being seen in the corporate market, with initial orders for its Invention Evaluator product secured through its partnership with 360 Impact Studio, alongside a direct corporate engagement focused on AI-based computer vision and object annotation technology.
Further corporate discussions were ongoing.
Academic demand remained strong, with new and repeat engagements secured from universities in the US, Chile and Singapore.
"We are encouraged by the strong year-on-year growth in the business and the increasing use of our higher-value portfolio products," said chief executive Melissa Cruz.
"Positive feedback from existing clients is leading to inbound referrals, and our partnerships are already generating corporate orders, expanding our corporate client base."
She added that ongoing discussions with institutions met through the company's marketing and event activity underpin confidence in the opportunity ahead.
At 1540 GMT, shares in GenIP were up 15.12% at 11.8p.
Reporting by Josh White for Sharecast.com.